Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 5 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 10 mg/ml; pyridoxine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. patients requiring parenteral b vitamin therapy who cannot tolerate intramuscular injections. 5. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that iv b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 6. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2 and b6. 7. peripheral neuritis caused by vari

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 100 mg/ml; riboflavine sodium phosphate, quantity: 2 mg/ml; nicotinamide, quantity: 20 mg/ml; dexpanthenol, quantity: 20 mg/ml; pyridoxine hydrochloride, quantity: 40 mg/ml; cyanocobalamin, quantity: 0.4 mg/ml - injection, solution - excipient ingredients: disodium edetate; benzyl alcohol; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7. carpal tunnel syndrome. 8. pernicious anaemia as a result of in situ b12 deficiency. general indications include: 1. angular stomatitis and glossitis have been shown in some instances to respond to t

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

Malta - English - Medicines Authority

wallace manufacturing chemists limited 51-53 stert street, abingdon, ox14 3jf, united kingdom - ascorbic acid, colecalciferol, dexpanthenol, nicotinamide, pyridoxine hydrochloride, thiamine hydrochloride, retinol palmitate, riboflavin, sodium ascorbate - oral drops, solution - ascorbic acid 19.35 mg colecalciferol 500 iu dexpanthenol 2 mg nicotinamide 12.5 mg pyridoxine hydrochloride 1 mg thiamine hydrochloride 2 mg retinol palmitate 5000 iu riboflavin 1 mg sodium ascorbate 34.44 mg - vitamins

United States - English - NLM (National Library of Medicine)

merit pharmaceutical - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - thiamine hydrochloride 100 mg in 1 ml - indications and usage:   in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. contraindications: sensitivity to the ingredients listed.

United States - English - NLM (National Library of Medicine)

agri laboratories, ltd. - thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e) - thiamine 1.25 mg in 1 ml - for animal use only keep out of reach of children indications for us as a supplemental source of a complex vitamins in cattle, swine and sheep.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - thiamine hydrochloride; dexpanthenol; pyridoxine hydrochloride; nicotinamide; riboflavin sodium phosphate - oral solution - 1mg/1ml ; 600microgram/1ml ; 400microgram/1ml ; 4mg/1ml ; 548microgram/1ml

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - dexpanthenol; glycine; lysine-l hydrochloride; methionine-dl; arginine-l hydrochloride; choline bitartrate; inositol; vitamin b12 = cyanocobalamin; vitamin b3 = nicotinamide; vitamin b2 as phosphate sodium = riboflavin as phosphate; vitamin b1 hydrochloride = thiamine hydrochloride; vitamin b6 hydrochloride = pyridoxine hydrochloride - parenteral liquid/solution/suspension - dexpanthenol ungrouped active 20.0 mg/ml; glycine amino acid-glycine active 20.0 mg/ml; lysine-l hydrochloride amino acid-lysine-l active 20.0 mg/ml; methionine-dl amino acid-methionine-dl active 20.0 mg/ml; arginine-l hydrochloride amino acid-arginine-l active 20.0 mg/ml; choline bitartrate vitamin-b complex active 5.0 mg/ml; inositol vitamin-b complex active 10.0 mg/ml; vitamin b12 = cyanocobalamin vitamin-b12 active 0.2 mg/ml; vitamin b3 = nicotinamide vitamin-b3 active 60.0 mg/ml; vitamin b2 as phosphate sodium = riboflavin as phosphate vitamin-b2 active 5.0 mg/ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 20.0 mg/ml; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 active 20.0 mg/ml - nutrition & metabolism - cat | cattle | dog | horse | beef | bitch | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castrate | cat - mineral and nutritional additive | acetonaemia | actinobacillosis | amino acid supplement | amino acids | bone fragility | bone growth | calcium supplement | cartilage strength | copper deficiency | egg shell | fatty acid deficiency | fatty liver | glucose | grass tetany | hepatotoxic drugs | hypocalcaemia | hypomagnesaemia | ileitis | iodine deficiencies | lactating | laxative | l-carnitine supplement | liver abscess | liver damage | lysine deficiencies | milk fever | mineral additive | myopathies | myositis syndrome | pangamic acid | phosphorous supplement | rickets | selenium deficiency | shell strength | soft bone disease | vitamin b12 | vitamin d supplement | vitamin e deficiencies | zinc deficiencies

United States - English - NLM (National Library of Medicine)

med-pharmex, inc - dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z) - dexpanthenol 250 mg in 1 ml - composition: each ml contains: dexpanthenol………………………………..250 mg benzyl alcohol…………………………...…1% w/v water for injection……………….…………….. q.s. acetic acid, glacial, usp………….. to adjust ph indications: for use as a nutritional source of dexpanthenol. for animal use only keep out of reach of children take time observe label directions contraindications: in therapy of colic resulting from the administration of cholinergic type anthelmintics.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

baxter healthcare ltd - nicotinamide; biotin; dexpanthenol; folic acid; cyanocobalamin; pyridoxine hydrochloride; thiamine; riboflavin sodium phosphate; ascorbic acid; retinol; colecalciferol; alpha tocopherol - powder for solution for injection - 46mg ; 69microgram ; 17.25mg ; 414microgram ; 6microgram ; 4.53mg ; 3.51mg ; 4.14mg ; 125mg ; 3500unit ; 220unit ; 11.2unit